ARS Pharmaceuticals, Inc. (SPRY)
3.15
+0.36
(+12.90%)
USD |
NASDAQ |
Nov 09, 16:00
3.22
+0.07
(+2.22%)
Pre-Market: 09:09
ARS Pharmaceuticals Cash and Short Term Investments (Quarterly) : 138.35M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 138.35M |
| June 30, 2026 | 143.84M |
| March 31, 2026 | 200.97M |
| December 31, 2025 | 244.99M |
| September 30, 2025 | 288.21M |
| June 30, 2025 | 240.13M |
| March 31, 2025 | 275.73M |
| December 31, 2024 | 314.02M |
| September 30, 2024 | 204.62M |
| June 30, 2024 | 218.74M |
| March 31, 2024 | 223.63M |
| December 31, 2023 | 228.36M |
| September 30, 2023 | 241.90M |
| June 30, 2023 | 252.21M |
| Date | Value |
|---|---|
| March 31, 2023 | 264.55M |
| December 31, 2022 | 274.38M |
| September 30, 2022 | 266.62M |
| June 30, 2022 | 257.98M |
| March 31, 2022 | 253.85M |
| December 31, 2021 | 60.06M |
| September 30, 2021 | 300.66M |
| June 30, 2021 | 359.69M |
| March 31, 2021 | 374.20M |
| December 31, 2020 | 386.57M |
| September 30, 2020 | 142.32M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 9.976M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 237.93M |
| Sionna Therapeutics, Inc. | 211.03M |
| Nektar Therapeutics | 684.34M |
| Ardelyx, Inc. | 285.34M |
| Kyntra Bio, Inc. | 91.32M |